Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-25-029726
Filing Date
2025-09-23
Accepted
2025-09-23 16:08:07
Documents
15
Effectiveness Date
2025-09-23
Reference 429
333-272897

Document Format Files

Seq Description Document Type Size
1 FORM S-8 aytu20250613_s8.htm S-8 115909
2 EXHIBIT 5.1 ex_832864.htm EX-5.1 6007
3 EXHIBIT 23.1 ex_831142.htm EX-23.1 2423
4 EXHIBIT FILING FEES ex_831143.htm   iXBRL EX-FILING FEES 16242
5 aytu20250613_s8img001.jpg GRAPHIC 3192
  Complete submission text file 0001437749-25-029726.txt   265199

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT ex_831143_htm.xml XML 4842
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-290469 | Film No.: 251333708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)